- Home
- XFOR vs TDUP Comparison
XFOR vs TDUP Comparison
Compare XFOR & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- TDUP
- Stock Information
- Founded
- XFOR 2014
- TDUP 2009
- Country
- XFOR United States
- TDUP United States
- Employees
- XFOR N/A
- TDUP N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- TDUP Catalog/Specialty Distribution
- Sector
- XFOR Health Care
- TDUP Consumer Discretionary
- Exchange
- XFOR Nasdaq
- TDUP Nasdaq
- Market Cap
- XFOR 118.4M
- TDUP 111.5M
- IPO Year
- XFOR N/A
- TDUP 2021
- Fundamental
- Price
- XFOR $0.40
- TDUP $0.92
- Analyst Decision
- XFOR Strong Buy
- TDUP Buy
- Analyst Count
- XFOR 4
- TDUP 6
- Target Price
- XFOR $2.88
- TDUP $3.40
- AVG Volume (30 Days)
- XFOR 4.9M
- TDUP 1.5M
- Earning Date
- XFOR 11-13-2024
- TDUP 11-04-2024
- Dividend Yield
- XFOR N/A
- TDUP N/A
- EPS Growth
- XFOR N/A
- TDUP N/A
- EPS
- XFOR N/A
- TDUP N/A
- Revenue
- XFOR $1,123,000.00
- TDUP $313,757,000.00
- Revenue This Year
- XFOR N/A
- TDUP N/A
- Revenue Next Year
- XFOR $596.79
- TDUP N/A
- P/E Ratio
- XFOR N/A
- TDUP N/A
- Revenue Growth
- XFOR N/A
- TDUP 0.58
- 52 Week Low
- XFOR $0.26
- TDUP $0.50
- 52 Week High
- XFOR $1.60
- TDUP $2.60
- Technical
- Relative Strength Index (RSI)
- XFOR 39.99
- TDUP 59.43
- Support Level
- XFOR $0.26
- TDUP $0.86
- Resistance Level
- XFOR $0.68
- TDUP $1.00
- Average True Range (ATR)
- XFOR 0.08
- TDUP 0.13
- MACD
- XFOR -0.01
- TDUP 0.03
- Stochastic Oscillator
- XFOR 34.01
- TDUP 74.88
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.